Delivery Order SPE2DR25D1205-SPE2DR26F0VY8
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Dexmedetomidine 200 mcg/2 mL in 2 mL vials, with a ceiling value of $1,359.50. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Dexmedetomidine 400 micrograms per 100 milliliters in normal saline solution (100 milliliters). The contract has a ceiling value of $11,209.75 and is structured as a firm fixed price delivery order with an ultimate completion date of May 21, 2025. This award was not designated as a set-aside contract, indicating it was competitively awarded. The place of performance is...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Dexmedetomidine 200 mcg/2 mL in 2 mL vials. This competitive award, which carries a ceiling value of $1,252.58 and is scheduled for completion by September 30, 2025, is issued under a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $1,577.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexmedetomidine 200 MCG/2 ML in 2 ML vials. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction within the company's broader pharmaceutical supply portfolio...
- This delivery order, valued at $1,278.66, awards AmerisourceBergen Drug Corp a contract to supply Dexmedetomidine 400mcg/100mL in 100mL vials to the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 29, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,543.69 firm fixed-price contract is for the supply of Dexmedetomidine 400mcg/100ml-NS 100ml, a medication used for sedation. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- On September 29, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Dexmedetomidine 200 mcg/2 ml (2 ml vials) with a ceiling value of $2,124.19. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 30, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $2,705.43, is for the supply of the pharmaceutical product Dexmedetomidine 400mcg/100ml-NS 100ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a period of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The contract has a ceiling value of $1,708.81 and a period of performance through March 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. federal government awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of the drug Dexmedetomidine 400mcg/100ml-NS 100ml. The $2,167.80 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which manages logistics and acquisition for the Department of Defense (DoD). This contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...